ICL Israel Chemicals Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.1% | -1.2% | -2.4% | +3.2% | -2.1% | +3.3% | +5.9% | -0.9% | +1.2% | +4.8% | +1.4% | |
| – | +2.4% | -3.1% | -6.1% | +4.3% | -6.2% | +7.0% | +10.4% | -4.4% | +2.9% | +6.9% | +1.1% | |
| – | +36.8% | -13.6% | -20.9% | +36.9% | -16.8% | -4.6% | +86.5% | -38.8% | -18.3% | +39.9% | +21.9% | |
| – | +26.2% | -18.2% | -18.2% | +27.0% | -12.1% | -2.0% | +61.9% | -32.1% | +4.2% | +17.1% | +13.9% | |
| – | -7.5% | -7.7% | -4.2% | +21.1% | -15.5% | +21.4% | -19.3% | -1.0% | +14.7% | +1.5% | -0.5% | |
| – | -1.1% | -4.3% | -5.3% | +3.0% | +2.2% | +0.2% | +3.7% | +5.2% | +8.8% | -3.6% | -1.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +74.6% | – | |
| – | -59.7% | +161.5% | -4.5% | +6.9% | -64.4% | +181.6% | +2.5% | +2.2% | -58.1% | – | – | |
| – | +4.2% | -2.6% | -4.1% | +3.9% | -1.6% | +4.4% | +9.7% | -3.7% | +4.9% | +8.3% | +0.9% | |
| – | +15.4% | -7.5% | -7.3% | +8.3% | -5.0% | +11.8% | -6.8% | +16.3% | +11.0% | +3.3% | -12.3% | |
| – | +44.9% | -27.4% | -7.4% | +5.0% | -36.6% | +48.4% | -36.0% | +115.6% | +11.3% | +5.7% | -30.2% | |
| – | +12.0% | +0.2% | -8.8% | +10.4% | +8.8% | +2.9% | +4.9% | -6.1% | +13.9% | +2.4% | -7.8% | |
| – | -18.1% | +15.9% | -1.8% | -0.3% | -6.6% | +7.7% | +37.4% | -25.7% | -10.0% | +30.5% | +19.2% | |
| – | +1.8% | -0.1% | -0.3% | +2.2% | -2.5% | +2.1% | +2.9% | +2.0% | -2.5% | +1.1% | +1.7% | |
| – | +0.1% | +0.8% | +1.2% | +0.9% | +0.3% | +0.7% | +0.7% | +1.1% | -2.4% | +1.1% | +1.2% | |
| – | 0.0% | 0.0% | 0.0% | +0.0% | 0.0% | +0.0% | +0.1% | -0.1% | 0.0% | -0.1% | +0.0% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.